NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) - ANVISA Registration 80785070151

Access comprehensive regulatory information for NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80785070151 and manufactured by Vida Biotecnologia Ltda - ME. The registration is held by Vida Biotecnologia Ltda - ME with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTICS DIVISION, LABTEST DIAGNOSTICA S/A, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80785070151
Registration Details
ANVISA Registration Number: 80785070151
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80785070151

25351702690202119

11308834000185

Company Information

Brazil
PT: BRASIL

Dates and Status

Dec 16, 2021

VIGENTE

09/18/2025 19:00:01